Latest stories on TCRT
Alaunos Therapeutics Regains Nasdaq Compliance After Financing
TipRanks62 · neutralgeneral
Alaunos Therapeutics, Inc. (TCRT) files 8-K
SEC 8-K50 · neutralgeneral
Alaunos Therapeutics, Inc. (TCRT) files 8-K
SEC 8-K38 · neutralgeneral
Alaunos Therapeutics announces completion of Velaris acquisition
The Fly63 · neutralm&a
Alaunos Therapeutics Announces Acquisition of Velaris Therapeutics
Business Insider58 · neutralm&a
Alaunos Therapeutics Announces Acquisition of Velaris Therapeutics
GlobeNewswire58 · neutralm&a
BC-Most Active Stocks
Yahoo Finance50 · neutralgeneral
Alaunos Therapeutics, Inc. (TCRT) files 8-K
SEC 8-K50 · neutralgeneral
Alaunos Therapeutics Faces Nasdaq Delisting, Seeks Hearing
TipRanks32 · bearishgeneral
Alaunos Therapeutics, Inc. (TCRT) files 8-K
SEC 8-K32 · bearishgeneral
Alaunos Therapeutics, Inc. (TCRT) files 8-K
SEC 8-K50 · neutralgeneral
Alaunos Therapeutics prices registered direct offering to raise ~$1.12 million
Seeking Alpha24 · bearishgeneral
Alaunos Therapeutics prices 380,469 shares at $1.46 in registered direct offer
The Fly24 · bearishgeneral
Alaunos Therapeutics, Inc. Announces Pricing of Registered Direct Offering priced at-the-market under Nasdaq rules
GlobeNewswire28 · bearishgeneral
Alaunos Therapeutics, Inc. (TCRT) files 8-K
SEC 8-K50 · neutralgeneral
Alaunos Reports New Preclinical Liver Data for ALN1003
TipRanks59 · neutralproduct/pr
Alaunos Therapeutics, Inc. (TCRT) files 8-K
SEC 8-K50 · neutralgeneral
Alaunos Reports Broad Metabolic Improvements with ALN1003 in Obese Mouse Studies | TCRT Stock News
StockTitan63 · neutralproduct/pr